Westerkirk Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
12,296
-19,835
-62% -$1.81M 0.11% 111
2026
Q1
$3.3M Sell
32,131
-800
-2% -$90.3K 0.36% 59
2025
Q4
$4.13M Buy
32,931
+23,578
+252% +$3M 0.4% 52
2025
Q3
$1.25M Sell
9,353
-9,217
-50% -$1.21M 0.14% 123
2025
Q2
$2.53M Buy
+18,570
New +$2.45M 0.31% 66

Other funds holding ABT

Westerkirk Capital's ABT Position: Q2 2026 in Review

Westerkirk Capital reduced its Abbott (ABT) stake by 62% in Q2 2026, selling an estimated $1.81M and leaving 12,296 shares worth $1.12M. The position accounts for 0.11% of the portfolio, ranked #111.

Westerkirk Capital first reported a position in ABT in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.13M in Q4 2025. 2,975 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Westerkirk Capital held 12,296 shares of Abbott worth $1.12M as of Q2 2026.
  • Westerkirk Capital sold 19,835 Abbott shares in Q2 2026, an estimated $1.81M.
  • Abbott made up 0.11% of Westerkirk Capital's portfolio in Q2 2026, its #111 holding.
  • Westerkirk Capital first reported a position in Abbott in Q2 2025 and has held it in 5 quarters since.
  • Westerkirk Capital's Abbott position peaked at $4.13M in Q4 2025.
  • 2,975 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Westerkirk Capital's 13F filing for Q2 2026, filed 10 Aug 2026.